Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults.
Nowak, Kristen L; Bartz, Traci M; Dalrymple, Lorien; de Boer, Ian H; Kestenbaum, Bryan; Shlipak, Michael G; Garimella, Pranav S; Ix, Joachim H; Chonchol, Michel.
J Am Soc Nephrol
; 28(4): 1239-1246, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28122946
Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study.
Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.
Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage: Nested Case-Control Study.
Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
Prediabetes is Characterized by Higher FGF23 Levels and Higher Prevalence of Vitamin D Deficiency Compared to Normal Glucose Tolerance Subjects.
Herd- and cow-level risk factors associated with subclinical mastitis in dairy farms from the High Plains of the northern Antioquia, Colombia.
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.
Mineral metabolites and CKD progression in African Americans.